n(g),n(g')-dimethyl-l-arginine has been researched along with Cancer of Prostate in 2 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reddy, KRK | 1 |
| Dasari, C | 2 |
| Duscharla, D | 1 |
| Supriya, B | 2 |
| Ram, NS | 1 |
| Surekha, MV | 1 |
| Kumar, JM | 2 |
| Ummanni, R | 2 |
| Kami Reddy, KR | 1 |
| Vandavasi, S | 1 |
| Natani, S | 1 |
| Jadav, SS | 1 |
| Sai Ram, N | 1 |
2 other studies available for n(g),n(g')-dimethyl-l-arginine and Cancer of Prostate
| Article | Year |
|---|---|
Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).
Topics: Amidohydrolases; Animals; Arginine; Cell Movement; Cell Proliferation; Fibroblast Growth Factor 2; G | 2018 |
Novel Cellularly Active Inhibitor Regresses DDAH1 Induced Prostate Tumor Growth by Restraining Tumor Angiogenesis through Targeting DDAH1/ADMA/NOS Pathway.
Topics: Amidohydrolases; Animals; Antineoplastic Agents; Arginine; Cell Line, Tumor; Cell Proliferation; Cel | 2019 |